Hamad Medical Coorporation
Doha, Qatar
NCT Number: NCT03076528
Among patients with diabetes 35% suffer from chronic renal disease and may require dialysis or kidney replacement over time. Furthermore, in diabetics with end stage renal disease (ESRD) that require dialysis, the risk of foot complications and amputation is even more common, expensive, and devastating. Interestingly, even though incidence of foot ulcers in patients with dialysis has been reported to be same as with patients with history of foot ulcers; dialysis patients have significantly higher rate of foot amputation.
The goal of this research is to incorporate an innovative virtually supervised non-weight bearing exercise in patients undergoing dialysis to reduce risk of fall and foot ulceration by enhancing lower extremity blood flow, joint perception and joint mobility.
Diabetic patients on hemodialysis at Hamad Medical Company will be recruited and will be randomized to either intervention (IG) or control (CG) group and followed for 6 months. The intervention group will take part in a 4-week non-weight bearing exercise program twice per week at the hemodialysis clinic under the supervision of a qualified research staff member. This intervention includes interactive game-based exercises including repetitive ankle and foot movements. Wearable sensors will provide real-time visual/auditory feedback from foot and ankle position and allowed perception of motor-errors during each motor-action. The control group will be instructed to complete a supervised foot and ankle exercise without using sensor technology. Changes in balance, gait, and physical activity, incidence of foot problems will be compared pre- and post-intervention. In addition, the incident of falls, foot ulcers, and limb amputation up to 6 months post intervention will be documented. Investigators hypothesize that patients receiving sensor-based exercises will benefit more compared to group receiving conventional non-technology training in terms of improving functional performance and reducing incidence of foot problems, falls, and limb amputation.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Phase 2
Doha, Qatar
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This intervention includes interactive game-based lower extremity training including repetitive ankle movements in multiple directions. Wearable sensors will provide real-time feedback from foot and ankle position and allow perception of motor-errors during each motor-action
Subjects are asked to perform non-technology based foot and ankle exercises, which include plantar flexion and extension.
Time frame: Baseline and 4 weeks
walking ability is quantified by gait speed
Time frame: Baseline and 4 weeks
Balance is quantified by body sway
Time frame: Baseline and 4 weeks
Measuring fear of falling using Fall Efficacy Scale International (FES-I) questionnaire
Time frame: Baseline to 4 weeks
Measuring depression using Center of Epidemiologic Depression Scale (CES-D) questionnaire
Time frame: Baseline and 6 months
Time frame: Baseline and 6 months
Baylor College of Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01602718
Behavior, Chronic Disease
View Trial DetailsNCT01809288
Behavior, Body Weight
Bethesda, Maryland, United States
View Trial DetailsNCT07555327
Anuria, Chronic Disease
Bordj Bou Arreridj, Wilaya de Bordj Bou Arréridj, Algeria
View Trial DetailsNCT03898206
Behavior, Cardiovascular Diseases
Bedford, Bedfordshire, United Kingdom
View Trial Details